Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 23, 2025 07:00 ET | Source: SAB Biotherapeutics, Inc.

SAB BIO Announces R&D Webinar Event to Review Phase 1 Topline Results for SAB-142, a Disease-Modifying T1D Therapy

SAB to host webinar event to discuss Phase 1 clinical trial topline results
April 08, 2024 07:15 ET | Source: SAB Biotherapeutics, Inc.

SAB Biotherapeutics to Present at INNODIA Annual Meeting

SAB Biotherapeutics, Inc. today announced their Chief Medical Officer will share an overview of the SAB-142 clinical development plan at INNODIA.